SEQIRUS

Welcome to the Brand page for “SEQIRUS”, which is offered here for Vaccines; blood products, immunoglobulins for medical or clinical use; serums for the treatment of influenza; antibodies; influenza vaccines; adjuvants and antigens; pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders, or diseases caused by bacteria and viruses; blood products, blood plasma, and reagent blood cells; products derived from blood and products derived from recombinant dna technology, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, rhd reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, reagent red blood cells used to detect antibodies or igg subtypes; pharmaceutical preparations, monoclonal and polyclonal antibodies, and antibodies for use in the treatment of infectious diseases; pharmaceutical preparations, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes;chemical and biological reagents for scientific use and/or for non-medical purposes; cell cultures and media for scientific use and/or for non-medical purposes; test kits for scientific and/or non-medical use for anti-body screening, blood grouping or for detection of specific blood cells, antigens or immunoglobulin subtypes; chemical preparations for scientific and/or industrial purposes; diagnostic and testing agents for scientific use and/or for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells;medical services; medical information services; health care services; health care information services; providing medical information concerning blood products; providing medical information concerning vaccines, anti-venoms and immunohaematology products, diagnostic reagents; patient support services, providing an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community;.

Its status is currently believed to be active. Its class is unavailable. “SEQIRUS” is believed to be currently owned by “bioCSL Inc.”